General Information
Product name
Human Influenza A/Hong Kong/8/68 (H3N2) Purified Virus
Emergency telephone
1-800-255-3924, (410) 792-9779 1.4
Icons in SDS
Company Information
company name
Advanced Biotechnologies, Inc
GHS Information
Signal word
Not Regulated
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
Hazard pictograms
Not Regulated
Signal word
Not Regulated
Hazardous Ingredients
None
Hazard statements
Not Regulated
2.3 Other hazards
This preparation of Human Influenza Virus is a BIOHAZARDOUS material containing ACTIVE VIRUS and should be handled in accordance with biosafety guidelines defined in the BMBL, NIH-CDC HHS Publication No. (CDC) 21-1112. Category: WHO Risk Group 2 Emergency Overview: Biohazardous Pathogenicity: An acute viral disease of the upper respiratory tract characterized by fever, headache, myalgia, malaise, sore throat, non-productive cough, sneezing and nasal discharge. Among children, otitis media, nausea and vomiting are commonly reported. Pulmonary complications of influenza include pneumonia (viral and bacterial), croup, asthma and bronchitis. Myocarditis and pericarditis are occasional cardiac complications. Fatality due to influenza is generally low, except in those with chronic lung or heart conditions. Secondary bacterial pneumonia after influenza is a leading cause of mortality worldwide. Host Range: Humans.
PBT Substances
Not applicable
vPvB Substances
Not applicable
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 This product is not classified as hazardous according to the Regulation (EC) No 1272/2008 and subsequent amendments. This product is not classified as hazardous according to the Globally Harmonized System (GHS) This product is not classified as hazardous according to OSHA GHS regulations within the U.S.